CRC
HZNP

Curi RMB Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Curi RMB Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-211,807
Closed -$3.01M – 1000
2018
Q1 		$3.01M Buy
211,807
+656
+0.3% +$9.69K 0.08% 320
2017
Q4 		$3.08M Buy
211,151
+42,688
+25% +$600K 0.08% 308
2017
Q3 		$2.14M Buy
168,463
+68,430
+68% +$870K 0.06% 354
2017
Q2 		$1.19M Buy
+100,033
New +$1.24M 0.03% 427

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Curi RMB Capital's HZNP Position: Q2 2018 in Review

Curi RMB Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2018, closing a stake of 211,807 shares — an estimated $3.01M sold.

Curi RMB Capital first reported a position in HZNP in Q2 2017 and held it in 4 quarters. The position peaked at $3.08M in Q4 2017. 204 funds tracked by Wall St. Rank hold HZNP as of Q2 2018.

  • Curi RMB Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • Curi RMB Capital sold 211,807 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2018, an estimated $3.01M.
  • Curi RMB Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 4 quarters.
  • Curi RMB Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.08M in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2018.

Based on Curi RMB Capital's 13F filing for Q2 2018, filed 13 Aug 2018.